Menu
Global B2B sourcing platform
Verified suppliers and manufacturers

GMP Quality Lab Raw Lyophilized Powder Cibinetide Acetate Ara-290 CAS 1208243-50-8 Peptide 10mg Vials

Price $65.00
Min Order 1 Kit
Availability In Stock
Shipping From Hubei, China
Popularity 410 people viewed
Model NO.:
1208243-50-8
CAS No.:
1208243-50-8
Formula:
N/a
EINECS:
N/a
Type:
for Research Use Only
Appearance:
Powder
Quality:
Refined
Colour:
White
Content:
Standard
Usage:
Laboratory Reagents
Source:
Dry Powder
Habit Appellation:
Fine Chemicals
Application:
Scientific Research
Property:
Protein and Peptide
Specific Usage:
Research Use Only
Note:
No Tfa Salt
From:
Authoried Regluar Workshop
Raw Powder:
1g/Bottle
Vials:
2mg 5mg 10mg
Attention:
Research Use Only
Trademark:
Hoconbio
Transport Package:
Customized
Specification:
1G/Bottle 50mg 100mg per vial
Origin:
China
Product Description

Product Name

ARA-290

OtherCibinetide
CAS NO.1208243-50-8
AppearanceWhite freeze-dried powder 
Purity98% HPLC 
ApplicationResearch peptides
Shelf Life 24 Months
StorageStore at a temperature of 2-8 degrees, protected from light.
ARA-290 is a peptide that is derived from e rythropoietin (EPO). EPO has been utilized for decades because of its ability to stimulate red blood cell production within bone marrow. It can also alter a patient's blood pressure, promote cell survival, and create a neuroprotective effect.
While ARA-290 does not stimulate red blood cell production, it does offer pain-relieving and neuroprotective effects.
It also has the potential to stimulate wound repair in patients with chronic diabetes, but this property is still being researched. 
ARA-290 is being studied as a potential treatment for systemic lupus erythematosus, as well.



Application & Function
The full scope of ARA-290s benefits is still being researched. However, it has the potential to decrease the user's inflammatory pathways through a process known as paracrine signaling. It has also been linked to reduced HbA1c and improved cholesterol numbers. Studies that have produced these results are still in the trial stages.
Perhaps the most appealing possibility for ARA-290 is that it may have the ability to reduce neuropathic symptoms and stimulate natural wound repair processes. 
This peptide serves as an exciting treatment option for patients that are dealing with chronic neuropathic pain and diabetes-related ailments. 

 


 

  • Similar Products
Full Page Contact Supplier